Your browser doesn't support javascript.
loading
Airway antibodies emerge according to COVID-19 severity and wane rapidly but reappear after SARS-CoV-2 vaccination.
Cagigi, Alberto; Yu, Meng; Österberg, Björn; Svensson, Julia; Falck-Jones, Sara; Vangeti, Sindhu; Åhlberg, Eric; Azizmohammadi, Lida; Warnqvist, Anna; Falck-Jones, Ryan; Gubisch, Pia C; Ödemis, Mert; Ghafoor, Farangies; Eisele, Mona; Lenart, Klara; Bell, Max; Johansson, Niclas; Albert, Jan; Sälde, Jörgen; Pettie, Deleah D; Murphy, Michael P; Carter, Lauren; King, Neil P; Ols, Sebastian; Normark, Johan; Ahlm, Clas; Forsell, Mattias N; Färnert, Anna; Loré, Karin; Smed-Sörensen, Anna.
Afiliación
  • Cagigi A; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Yu M; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Österberg B; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Svensson J; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Falck-Jones S; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Vangeti S; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Åhlberg E; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Azizmohammadi L; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Warnqvist A; Unit of Biostatistics, Institute of Environmental Medicine, and.
  • Falck-Jones R; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Gubisch PC; Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
  • Ödemis M; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Ghafoor F; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Eisele M; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Lenart K; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Bell M; Division of Immunology and Allergy, Department of Medicine Solna, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden.
  • Johansson N; Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden.
  • Albert J; Department of Perioperative Medicine and Intensive Care, Karolinska University Hospital, Stockholm, Sweden.
  • Sälde J; Division of Infectious Diseases, Department of Medicine Solna, Center for Molecular Medicine, Karolinska Institutet, Stockholm, Sweden.
  • Pettie DD; Department of Infectious Diseases, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Murphy MP; Department of Microbiology, Tumor and Cell Biology, Karolinska Institutet, Stockholm, Sweden.
  • Carter L; Division of Clinical Microbiology, Karolinska University Laboratory, and.
  • King NP; Närakut SLSO, Karolinska University Hospital Solna, Stockholm, Sweden.
  • Ols S; Department of Biochemistry and.
  • Normark J; Institute for Protein Design, University of Washington, Seattle, Washington, USA.
  • Ahlm C; Department of Biochemistry and.
  • Forsell MN; Institute for Protein Design, University of Washington, Seattle, Washington, USA.
  • Färnert A; Department of Biochemistry and.
  • Loré K; Institute for Protein Design, University of Washington, Seattle, Washington, USA.
  • Smed-Sörensen A; Department of Biochemistry and.
JCI Insight ; 6(22)2021 11 22.
Article en En | MEDLINE | ID: mdl-34665783
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoglobulina A / Inmunoglobulina G / Inmunización Secundaria / Anticuerpos Neutralizantes / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Pulmón / Anticuerpos Antivirales Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JCI Insight Año: 2021 Tipo del documento: Article País de afiliación: Suecia
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Inmunoglobulina A / Inmunoglobulina G / Inmunización Secundaria / Anticuerpos Neutralizantes / Vacunas contra la COVID-19 / SARS-CoV-2 / COVID-19 / Pulmón / Anticuerpos Antivirales Tipo de estudio: Observational_studies / Prognostic_studies Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: JCI Insight Año: 2021 Tipo del documento: Article País de afiliación: Suecia